glp 1 pill reviews GLP-1 vs Shots: What to Consider Video A new pill form
Description
Prusogliptin, developed by CSPC Ouyi Pharmaceutical, is a novel oral dipeptidyl peptidase-4 (DPP-4) inhibitor that was approved by NMPA on January 8, 2025.
99% purity, HPLC-tested, COA
However, although modern glucagon-like peptide-1 receptor agonists and related medications are highly effective for weight loss and glycaemic improvement, and generally safe, many people do not want to take drugs indefinitely, and their cost means that they are not available across much of the world
market in October 2010
Founders and investors see massive potential in the new drug class but funding is yet to flood startups in the sector.
